Polyreactive antigen-binding B (PAB+) cells are widely distributed and the PAB+ population consists of both B-1+ and B-1- phenotypes

Clinical and Experimental Immunology

Volumn 137, Issue 1, 2004, Pages 88-100

  Zhou, Z H ^a   Notkins, A L ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

B cell receptor; Immunological tolerance; Innate immunity; Natural antibodies; Natural immunity

Indexed keywords

B LYMPHOCYTE RECEPTOR; CELL SURFACE MARKER;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN BINDING; ANTIGEN BINDING CELL; ARTICLE; B LYMPHOCYTE; CELL ISOLATION; CELL MUTANT; CELL POPULATION; CELL SUBPOPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENETIC VARIABILITY; IMMUNOLOGICAL TOLERANCE; LYMPHOID ORGAN; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; THYMUS;

ANIMALS; ANTIBODIES; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS; ANTIGENS, CD; ANTIGENS, SURFACE; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; CELLS, CULTURED; ENDOTOXINS; IMMUNE TOLERANCE; IMMUNITY, NATURAL; IMMUNOGLOBULIN M; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED STRAINS; PHENOTYPE; RECEPTORS, ANTIGEN, B-CELL; THYMUS GLAND;

EID: 3042697408     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02511.x     Document Type: Article

References (57)

1. Casali P, Notkins AL. Probing the human B-cell repertoire with EBV, polyreactive antibodies and CD5+ B lymphocytes. Annu Rev Immunol 1989; 7:513-35.
2. Satoh J, Prabhakar BS, Haspel MV, Ginsberg-Fellner F, Notkins AL. Human monoclonal autoantibodies that react with multiple endocrine organs. N Engl J Med 1983; 309:217-20.
3. Dighiero G, Lymberi P, Mazie JC et al. Murine hybridomas secreting natural monoclonal antibodies reacting with self antigens. J Immunol 1983; 131:2267-72.
4. Prabhakar BS, Saegusa J, Onodera T, Notkins AL. Lymphocytes capable of making monoclonal autoantibodies that react with multiple organs are a common feature of the normal B cell repertoire. J Immunol 1984; 133:2815-7.
5. Casali P, Burastero SE, Nakamura M, Inghirami G, Notkins AL. Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset. Science 1987; 236:77-81.
6. Burastero SE, Casali P, Wilder RL, Notkins AL. Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD5+ B cells from patients with rheumatoid arthritis. J Exp Med 1988; 168:1979-92.
7. Harindranath N, Ikematsu H, Notkins AL, Casali P. Structure of the VH and VL segments of polyreactive and monoreactive human natural antibodies to HIV-1 and Escherichia coli beta-galactosidase. Int Immunol 1993; 5:1523-33.
8. Ichiyoshi Y, Casali P. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments. J Exp Med 1994; 180:885-95.
9. Cheung SC, Takeda S, Notkins AL. Both VH and VL chains of polyreactive IgM antibody are required for polyreactivity: expression of Fab in Escherichia coli. Clin Exp Immunol 1995; 101:383-6.
10. Adib-Conquy M, Gilbert M, Avrameas S. Effect of amino acid substitutions in the heavy chain CDR3 of an autoantibody on its reactivity. Int Immunol 1998; 10:341-6.
11. Rini JM, Schulze-Gahmen U, Wilson IA. Structural evidence for induced fit as a mechanism for antibody-antigen recognition. Science 1992; 255:959-65.
12. Stanfield RL, Wilson IA. Antigen-induced conformational changes in antibodies: a problem for structural prediction and design. Trends Biotechnol 1994; 12:275-9.
13. Wedemayer GJ, Patten PA, Wang LH, Schultz PG, Stevens RC. Structural insights into the evolution of an antibody combining site. Science 1997; 276:1665-9.
14. Kramer A, Keitel T, Winkler K, Stocklein W, Hohne W, Schneider-Mergener J. Molecular basis for the binding promiscuity of an anti-p24 (HIV-1) monoclonal antibody. Cell 1997; 91:799-809.
15. Keitel T, Kramer A, Wessner H, Scholz C, Schneider-Mergener J, Hohne W. Crystallographic analysis of anti-p24 (HIV-1) monoclonal antibody cross-reactivity and polyspecificity. Cell 1997; 91:811-20.
16. Ramsland PA, Guddat LW, Edmundson AB, Raison RL. Diverse binding site structures revealed in homology models of polyreactive immunoglobulins. J Comput Aided Mol Des 1997; 11:453-61.
17. Schultz PG, Lerner RA. Completing the circle. Nature 2002; 418:485.
18. Hayakawa K, Hardy RR. Development and function of B-1 cells. Curr Opin Immunol 2000; 12:346-53.
19. Notkins AL. Polyreactive antibodies and polyreactive antigen-binding B (PAB) Cells. Curr Top Microbiol Immunol 2000; 252:241-9.
20. Potter M, Melchers F. Opinions on the nature of B-1 cells and their relationship to B cell neoplasia. Curr Top Microbiol Immunol 2000; 252:307-24.
21. Ochsenbein AF, Zinkernagel RM. Natural antibodies and complement link innate and acquired immunity. Immunol Today 2000; 21:624-30.
22. Scicluna LA, Bruckner L, McCullough KC. Qualitative assessment of the humoral immune status against FMDV in post-vaccination cattle. Vaccine 2001; 19:2975-86.
23. Chen ZJ, Wheeler J, Notkins AL. Antigen-binding B cells and polyreactive antibodies. Eur J Immunol 1995; 25:579-86.
24. Chen ZJ, Shimizu F, Wheeler J, Notkins AL. Polyreactive antigen-binding B cells in the peripheral circulation are IgD+ and B7. Eur J Immunol 1996; 26:2916-23.
25. Wang Z, Chen ZJ, Wheeler J, Shen S, Notkins AL. Characterization of murine polyreactive antigen-binding B cells: presentation of antigens to T cells. Eur J Immunol 2001; 31:1106-14.
26. Martin F, Kearney JF. B1 cells: similarities and differences with other B cell subsets. Curr Opin Immunol 2001; 13:195-201.
27. Rothstein TL. Cutting edge commentary: two B-1 or not to be one. J Immunol 2002; 168:4257-61.
28. Kasaian MT, Ikematsu H, Casali P. Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies. J Immunol 1992; 148:2690-702.
29. Berland R, Wortis HH. Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 2002; 20:253-300.
30. Wortis HH, Berland R. Cutting edge commentary, origins of B-1 cells. J Immunol 2001; 166:2163-6.
31. Chumley MJ, Dal Porto JM, Cambier JC. The unique antigen receptor signaling phenotype of B-1 cells is influenced by locale but induced by antigen. J Immunol 2002; 169:1735-43.
32. Martin F, Oliver AM, Kearney JF. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 2001; 14:617-29.
33. Kroese FG, de Waard R, Bos NA. B-1 cells and their reactivity with the murine intestinal microflora. Semin Immunol 1996; 8:11-8.
34. Ochsenbein AF, Fehr T, Lutz C, Suter M et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science 1999; 286:2156-9.
35. Baumgarth N, Herman OC, Jager GC, Brown LE, Herzenberg LA, Chen J. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 2000; 192:271-80.
36. Kalinke U, Oxenius A, Lopez-Macias C, Zinkernagel RM, Hengartner H. Virus neutralization by germ-line vs. hypermutated antibodies. Proc Natl Acad Sci USA 2000; 97:10126-31.
37. Hayakawa K, Hardy RR, Honda M, Herzenberg LA, Steinberg AD. Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sci USA 1984; 81:2494-8.
38. Kantor AB, Stall AM, Adams S, Herzenberg LA. Differential development of progenitor activity for three B-cell lineages. Proc Natl Acad Sci USA 1992; 89:3320-4.
39. Erickson LD, Foy TM, Waldschmidt TJ. Murine B1 B cells require IL-5 for optimal T cell-dependent activation. J Immunol 2001; 166:1531-9.
40. Arnold LW, Pennell CA, McCray SK, Clarke SH. Development of B-1 cells: segregation of phosphatidyl choline-specinc B cells to the B-1 population occurs after immunoglobulin gene expression. J Exp Med 1994; 179:1585-95.
41. Casali P, Burastero SE, Balow JE, Notkins AL. High-affinity antibodies to ssDNA are produced by CD-B cells in systemic lupus erythematosus patients. J Immunol 1989; 143:3476-83.
42. Chen X, Martin F, Forbush KA, Perlmutter RM, Kearney JF. Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int Immunol 1997; 9:27-41.
43. Heltemes LM, Manser T. Level of B cell antigen receptor surface expression influences both positive and negative selection of B cells during primary development. J Immunol 2002; 169:1283-92.
44. Lu TT, Cyster JG. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science 2002; 297:409-12.
45. high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J Immunol 1999; 162:7198-207.
46. Tumas-Brundage KM, Notidis E, Heltemes L, Zhang X, Wysocki LJ, Manser T. Predominance of a novel splenic B cell population in mice expressing a transgene that encodes multireactive antibodies support for additional heterogeneity of the B cell compartment. Int Immunol 2001; 13:475-84.
47. Ceredig R. The ontogeny of B cells in the thymus of normal, CD3 epsilon knockout (KO), RAG-2 KO and IL-7 transgenic mice. Int Immunol 2002; 14:87-99.
48. Ternynck T, Avrameas S. Murine natural monoclonal autoantibodies: a study of their polyspecificities and their affinities. Immunol Rev 1986; 94:99-112.
49. Sigounas G, Harindranath N, Donadel G, Notkins AL. Half-life of polyreactive antibodies. J Clin Immunol 1994; 14:134-40.
50. Sigounas G, Kolaitis N, Monell-Torrens E, Notkins AL. Polyreactive IgM antibodies in the circulation are masked by antigen binding. J Clin Immunol 1994; 14:375-81.
51. Chen ZJ, Wheeler CJ, Shi W, Wu AJ, Yarboro CH, Gallagher M et al. Polyreactive antigen-binding B cells are the predominant cell type in the newborn B cell repertoire. Eur J Immunol 1998; 28:989-94.
52. Ferrero I, Anjuere F, Martin P, Martinez del Hoyo G, Fraga ML, Wright N et al. Functional and phenotypic analysis of thymic B cells: role in the induction of T cell negative selection. Eur J Immunol 1999; 29:1598-609.
53. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002; 298:1395-401.
54. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002; 29:197-216.
55. Ikematsu H, Kasaian MT, Schettino EW, Casali P. Structural analysis of the VH-D-JH segments of human polyreactive IgG mAb. Evidence for somatic selection. J Immunol 1993; 151:3604-16.
56. Ichiyoshi Y, Zhou M, Casali P. A human anti-insulin IgG autoantibody apparently arises through clonal selection from an insulin-specific 'germ-line' natural antibody template. Analysis by V gene segment reassortment and site-directed mutagenesis. J Immunol 1995; 154:226-38.
57. Arnold LW, McCray SK, Tatu C, Clarke SH. Identification of a precursor to phosphatidyl choline-specific B-1 cells suggesting that B-1 cells differentiate from splenic conventional B cells in vivo: cyclosporin A blocks differentiation to B-1. J Immunol 2000; 164:2924-30.